Updates in Later Line Multiple Myeloma Management

MyCancerHaven
R

Experts Discuss Current Approaches in Triple Class Refractory MM

By MyCancerHaven FEATURING Ravi Vij, Jeffrey Zonder, Joshua Richter
By MyCancerHaven FEATURING Ravi Vij, Jeffrey Zonder, Joshua Richter
278 views
February 20, 2024
Comments 0
Login to view comments. Click here to Login
16:17

CAR-T in MM: Best Practices in Patient Selection, Treatment, and Mul…

Icahn School of Medicine at Mount Sinai

A. Rossi

81 views
12:28

Updates on the Management of Later Relapses of Multiple Myeloma

UNC Lineberger Comprehensive Cancer Center

S. Rubinstein

91 views
21:17

Experts Discuss How They Plan to Use CAR-T in Myeloma After First Re…

MyCancerHaven

R. Vij, A. Abdallah

86 views
13:44

UChicago Medicine Best of ASCO® 2024: Myeloma

UChicago Medicine Annual Practice Updates in Hematology and Oncology

J. Cooperrider

89 views
12:51

Real-World Experience With Ide-Cel in R/R MM

Donna Reece

74 views
11:43

Practical Perspectives on Recent CAR-T FDA Approvals in Myeloma

City of Hope

M. Janakiram

294 views
14:34

Early Line CAR-Ts in Myeloma - Updates and Future Directions

Krina Patel

177 views
20:38

BCMA & Beyond: Novel Targets for Immunotherapy in MM

Rush University Medical Center

B. Derman

171 views
20:23

When to Consider Bispecific and CAR-T Therapy in MM

SOHO Brazil 2024

N. S. Raje

432 views
25:52

CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Direc…

Rush University Medical Center

A. Suvannasankha

209 views
26:46

CAR-Ts Earlier in MyelomaTherapy?: What We Learned From the Recent F…

Samer Al Hadidi

611 views
13:22

Managing Infectious Complications With Bispecific and CAR-T Therapy …

SOHO Brazil 2024

N. S. Raje

203 views
16:56

ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"

2024 ASCO® Annual Meeting Insights Hub

S. Parekh

249 views
22:45

CAR T-Cells in Multiple Myeloma in 2024

Dana-Farber Cancer Institute

A. Sperling

283 views
13:36

CAR T-Cell Therapies for Pts With R/R Myeloma: Updates From the Real…

Moffitt Cancer Center

D. Hansen

258 views
24:16

Future of Novel Next Generation Therapy in the Management of R/R MM

Dana-Farber Cancer Institute

P. Richardson

233 views
13:47

ASCO® 2024 Insights: "MRD2STOP Study - Discontinuation of Maintenanc…

2024 ASCO® Annual Meeting Insights Hub

B. Derman

407 views
22:50

Multiple Myeloma: Experts Discuss How to Choose Between CAR-Ts and B…

MyCancerHaven

R. Vij, N. Nathwani

268 views
03:42

Multiple Myeloma: What You Need to Know About New FDA Approvals of C…

Moffitt Cancer Center

D. Hansen

383 views
22:50

Multiple Myeloma: Understanding Your Immune Effector Therapeutic Opt…

Indy Hematology Review

S. Usmani

232 views
50:49

Multiple Myeloma: CAR T-Cells and Bispecifics - A Case for Moving Th…

UChicago Medicine

N. Raje

265 views
21:14

2024 Updates in MM: The Role of Immunotherapy

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

A. Cohen

300 views
24:29

How I Treat R/R MM With CAR-T and Bispecific Antibodies

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Cerchione

162 views
08:11

Triple-Class-Exposed R/R MM: Results From the KarMMa-3 Trial of Ide-…

Insights from 2023 ASH Annual Meeting

K. Patel

188 views
24:39

Multiple Myeloma: Adverse Effects of CAR-T

Icahn School of Medicine at Mount Sinai

S. Rajeeve

333 views